Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Centre Hospitalier Regional Universitaire De Montpellier currently manages a focused patent portfolio within the Biotechnology & Pharmaceuticals technology area. The company has 1 pending office action across its active filings. This workload is handled by 1 distinct examiner, indicating a concentrated prosecution pipeline at this stage. Such concentration often simplifies the management of intellectual property as it limits the number of examiner interactions required to advance the portfolio.
The prosecution activity is limited to 1 distinct art unit. SCHWECHTER, BRANDON ROSS is identified as the busiest examiner for the portfolio. This examiner is responsible for 1 pending office action, which represents the entirety of the company's current pending workload. The alignment of 1 distinct examiner to 1 distinct art unit suggests a narrow technical focus for the pending matters. For a practitioner, this means that the outcome of the entire pending portfolio currently rests on the decisions of the individual examiner within the patent office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHWECHTER, BRANDON ROSS | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18163026 | TARGETED MODIFIED IL-1 FAMILY MEMBERS | SCHWECHTER, BRANDON ROSS | — |
| Art Unit | Apps |
|---|---|
| 1674 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18163026 | TARGETED MODIFIED IL-1 FAMILY MEMBERS | SCHWECHTER, BRANDON ROSS | 1674 | §112 | Non-Final OA | — | Pending | Feb 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCentre Hospitalier Regional Universitaire De Montpellier has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Brandon Ross Schwechter has the most, with 1 of Centre Hospitalier Regional Universitaire De Montpellier's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
